A detailed history of Letko, Brosseau & Associates Inc transactions in Outset Medical, Inc. stock. As of the latest transaction made, Letko, Brosseau & Associates Inc holds 13,550 shares of OM stock, worth $13,008. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,550
Previous 13,550 -0.0%
Holding current value
$13,008
Previous $9,000 66.67%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 10, 2023

BUY
$17.18 - $23.76 $37,796 - $52,272
2,200 Added 19.38%
13,550 $296,000
Q4 2022

Feb 10, 2023

SELL
$12.36 - $26.41 $137,814 - $294,471
-11,150 Reduced 49.56%
11,350 $293,000
Q2 2021

Jul 29, 2021

BUY
$41.49 - $59.92 $933,525 - $1.35 Million
22,500 New
22,500 $1.13 Million

Others Institutions Holding OM

About Outset Medical, Inc.


  • Ticker OM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 48,007,300
  • Market Cap $46.1M
  • Description
  • Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was ...
More about OM
Track This Portfolio

Track Letko, Brosseau & Associates Inc Portfolio

Follow Letko, Brosseau & Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Letko, Brosseau & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Letko, Brosseau & Associates Inc with notifications on news.